Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 55154-0183

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 55154-0183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

150mg Bag Label (439a7e93 F578 434f 943f 4b93c35450f5 00)

150mg Bag Label (439a7e93 F578 434f 943f 4b93c35450f5 00)
This is a detailed description of BuPROPion Hydrochloride extended-release tablets, USP (SR) with a strength of 150 mg. It contains warnings, dosage information, storage instructions, and details on the manufacturer. The tablets are intended for twice-a-day use after initial titration and should be stored at 20°C to 25°C (68°F to 77°F). It is important not to use these tablets in combination with ZYBAN® or any other medications containing bupropion HCI. The packaging is a unit dose pack that is not child-resistant and is meant for institutional use only. The product is dispensed with a Medication Guide and is distributed by Major Pharmaceuticals in Indianapolis, USA.*
FDA Label Image

Chemical Structure (Structure)

Chemical Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.